Gene therapies targeting dystrophin exons for DMD

DISEASE CATEGORY: Musculoskeletal

INDICATION: Muscular dystrophy

Cell culture and mouse studies suggest CRISPR-Cas9-based gene therapies targeting exons 43 or 45

Read the full 193 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE